Hysynth Bio Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-06-2024
- Paid Up Capital ₹ 0.20 M
as on 26-06-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -43.21%
(FY 2016)
- Profit -33.10%
(FY 2016)
- Ebitda -7.06%
(FY 2016)
- Net Worth -134.54%
(FY 2016)
- Total Assets -19.15%
(FY 2016)
About Hysynth Bio Technologies
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Vijayakumar and Vasudevan Manimala serve as directors at the Company.
- CIN/LLPIN
U73200TN2013PTC089933
- Company No.
089933
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hysynth Bio Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayakumar  | Director | 03-May-2017 | Current |
| Vasudevan Manimala | Director | 06-Mar-2013 | Current |
Financial Performance of Hysynth Bio Technologies.
Hysynth Bio Technologies Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 43.21% decrease. The company also saw a substantial fall in profitability, with a 33.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 134.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hysynth Bio Technologies?
In 2016, Hysynth Bio Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
California Software Company LimitedActive 32 years 10 monthsVijayakumar and Vasudevan Manimala are mutual person
Global Allied Pharmaceuticals Private LimitedActive 9 years 6 monthsVijayakumar and Vasudevan Manimala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hysynth Bio Technologies?
Unlock and access historical data on people associated with Hysynth Bio Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hysynth Bio Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hysynth Bio Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
